Evidence map›Paper›PMID 40756894›Full record

ArticleJournal of the Royal Society of New Zealand2025

Community pharmacy density at national and subnational levels in New Zealand.

Michael J Leach

Abstract read
In one paragraph

Article in Journal of the Royal Society of New Zealand, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michael J LeachSchool of Rural Health, Monash University, Bendigo, Australia.ORCID https://orcid.org/0000-0003-1468-3474

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As community pharmacies provide essential pharmaceutical and public health services, they should be geographically accessible to populations globally. This study aimed to explore community pharmacy density and associated factors at national and subnational levels in New Zealand (NZ). Publicly available, aggregate data for 2020 were sourced. Community pharmacy density (number of community pharmacies per 10,000 population) was calculated at the national level and at the subnational level using territorial authority (TA) areas. Associations between four TA characteristics (type [cities or districts], island [North or South], older age and deprivation score) and continuous community pharmacy density were assessed via linear regression. There were 1,154 community pharmacies. Numbers of community pharmacies per 10,000 population were 2.27 for NZ, 2.25 and 2.33 for the North and South Islands, respectively, and 2.45 and 1.95 for cities and districts, respectively. The only TA characteristic associated with community pharmacy density was TA type: cities had significantly higher community pharmacy density than districts (adjusted

Indexed as

accessibilityCommunity pharmacygeographic information systemshealth services researchmedicinespolicy

Identifiers

PMID40756894
PMCPMC12315173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.